R.L. DashdamirovThe influence of eprosartan on quality of life and hemodynamic parameters in patients with arterial hypertension and metabolic syndrome

The arm of the study was to assess influence of long-term therapy with angiotensin II receptor blocker eprosartan on blood pressure, left ventricular hypertrophy, lipid, carbohydrate metabolism, anxiety and depression in 64 hypertensive patients with metabolic syndrome. The results of our study demonstrated that apart from good antihypertensive effect, eprosartan caused regression of left ventricular hypertrophy, increased quality of life and decreased degree of depression. No negative effect on lipid and carbohydrate metabolism was revealed.

Full article